[HTML][HTML] SARS-CoV-2: a master of immune evasion

A Rubio-Casillas, EM Redwan, VN Uversky - Biomedicines, 2022 - mdpi.com
Viruses and their hosts have coevolved for a long time. This coevolution places both the
pathogen and the human immune system under selective pressure; on the one hand, the …

[HTML][HTML] Implication of SARS-CoV-2 immune escape spike variants on secondary and vaccine breakthrough infections

L Ahmad - Frontiers in immunology, 2021 - frontiersin.org
COVID-19 pandemic remains an on-going global health and economic threat that has
amassed millions of deaths. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

PEGylated green halloysite/spinel ferrite nanocomposites for pH sensitive delivery of dexamethasone: A potential pulmonary drug delivery treatment option for COVID …

BR Jermy, V Ravinayagam, D Almohazey… - Applied Clay …, 2022 - Elsevier
Dexamethasone (Dex) is used in drug regimen for treatment of Coronavirus disease (COVID-
19). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) fusion and entry into …

Perfusion process for CHO cell producing monoclonal antibody: Comparison of methods to determine optimum cell specific perfusion rate

S Maria, L Bonneau, B Fould, G Ferry, JA Boutin… - Biochemical …, 2023 - Elsevier
Over twenty-five years ago, perfusion was applied to mammalian cells to produce
therapeutic proteins, mainly sensitive ones. Nowadays, other issues such as process …

[HTML][HTML] Prognostic serum biomarkers in cancer patients with COVID-19: a systematic review

TA Lee, SH Wang, CT Kuo, CW Li, LD McCullough… - Translational …, 2022 - Elsevier
Purpose Cancer patients with COVID-19 likely express biomarker changes in circulation.
However, the biomarkers used in SARS-CoV-2 infected cancer patients for COVID-19 …

[图书][B] Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV2 Infection: Revolutionary Strategies to Combat Pandemics

A Parihar, R Khan, A Kumar, AK Kaushik, H Gohel - 2022 - books.google.com
Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate
SARS-CoV2 Infection: Revolutionary Strategies to Combat Pandemics compiles information …

[HTML][HTML] Can serum interleukin 34 levels be used as an indicator for the prediction and prognosis of COVID-19?

D Karahan, HA Bolayir, A Bolayir, B Demir, Ö Otlu… - Plos one, 2024 - journals.plos.org
Objective Interleukin 34 (IL-34) is a molecule whose expression is increased in conditions
such as autoimmune disorders, inflammation, and infections. Our study aims to determine …

[PDF][PDF] Hematological, inflammatory, and novel biomarkers assessment as an eminent strategy for clinical management of COVID-19

S Rezaeian, F Razmjooei, M Pourmokhtari, A Abdoli… - Heliyon, 2023 - cell.com
Background Different biomarkers have been suggested as novel biomarkers of coronavirus
disease 2019 (COVID-19) theragnosis. With the aim of having a better clinical management …

[HTML][HTML] Current Technologies and Future Perspectives in Immunotherapy towards a Clinical Oncology Approach

S Adhikary, S Pathak, V Palani, A Acar, A Banerjee… - Biomedicines, 2024 - mdpi.com
Immunotherapy is now established as a potent therapeutic paradigm engendering antitumor
immune response against a wide range of malignancies and other diseases by modulating …

[HTML][HTML] Clinical characteristics of COVID-19 patients in Xiaogan, China: comparison between recent imported cases and earlier local cases

YL Hu, T Ding - American Journal of Translational Research, 2021 - ncbi.nlm.nih.gov
Object: In this study, we aim to investigate if there exists some change in the pathogenicity of
SARS-CoV-2 by comparing the clinical characteristics between recent imported patients and …